Claire Beaumont

Value of Mismatch Repair, <i>KRAS</i> , and <i>BRAF</i> Mutations in Predicting Recurrence and Benefits From Chemotherapy in Colorectal Cancer

Gordon Hutchins, Katie Southward, Kelly Handley et al. · Journal of Clinical Oncology · 2011 · 682 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Structural Characterization of Drug-like Compounds by Ion Mobility Mass Spectrometry: Comparison of Theoretical and Experimentally Derived Nitrogen Collision Cross Sections

Iain D. G. Campuzano, Matthew F. Bush, Carol V. Robinson et al. · Analytical Chemistry · 2011 · 383 citations

Natural Sciences, Chemistry, Pharmacology +13

Validation Study of a Quantitative Multigene Reverse Transcriptase–Polymerase Chain Reaction Assay for Assessment of Recurrence Risk in Patients With Stage II Colon Cancer

Richard Gray, Philip Quirke, Kelly Handley et al. · Journal of Clinical Oncology · 2011 · 376 citations · Full text

Medicine, Biostatistics, Oncology +17

Pharmacokinetics and tolerability of <scp>SRT</scp>2104, a first‐in‐class small molecule activator of <scp>SIRT</scp>1, after single and repeated oral administration in man

Ethan Hoffmann, J. Wald, Siva Lavu et al. · British Journal of Clinical Pharmacology · 2012 · 126 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +13

Tafenoquine treatment of Plasmodium vivax malaria: suggestive evidence that CYP2D6 reduced metabolism is not associated with relapse in the Phase 2b DETECTIVE trial

Pamela L. St. Jean, Zhengyu Xue, Nick Carter et al. · Malaria Journal · 2016 · 100 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17